作者
Hester C. Timmerhuis,Sven M. van Dijk,Robbert A. Hollemans,Christina J. Sperna Weiland,Devica S. Umans,Lotte Boxhoorn,Nora Hallensleben,Rogier van der Sluijs,Lieke Brouwer,Peter van Duijvendijk,Liesbeth M. Kager,Sjoerd D. Kuiken,Jan‐Werner Poley,Rogier de Ridder,Tessa E H Römkens,Rutger Quispel,Matthijs P. Schwartz,Adriaan C. Tan,Niels G. Venneman,Frank P. Vleggaar,Roy L.J. van Wanrooij,Ben J.�M. Witteman,Erwin JM van Geenen,I. Quintus Molenaar,Marco J. Bruno,Jeanin E. van Hooft,Marc G. Besselink,Rogier P. Voermans,Thomas L. Bollen,Robert C. Verdonk,Hjalmar C. van Santvoort
摘要
Necrotizing pancreatitis may result in a disrupted or disconnected pancreatic duct (DPD) with the potential for long-lasting negative impact on a patient's clinical outcome. There is a lack of detailed data on the full clinical spectrum of DPD, which is critical for the development of better diagnostic and treatment strategies.We performed a long-term post hoc analysis of a prospectively collected nationwide cohort of 896 patients with necrotizing pancreatitis (2005-2015). The median follow-up after hospital admission was 75 months (P25-P75: 41-151). Clinical outcomes of patients with and without DPD were compared using regression analyses, adjusted for potential confounders. Predictive features for DPD were explored.DPD was confirmed in 243 (27%) of the 896 patients and resulted in worse clinical outcomes during both the patient's initial admission and follow-up. During hospital admission, DPD was associated with an increased rate of new-onset intensive care unit admission (adjusted odds ratio [aOR] 2.52; 95% confidence interval [CI] 1.62-3.93), new-onset organ failure (aOR 2.26; 95% CI 1.45-3.55), infected necrosis (aOR 4.63; 95% CI 2.87-7.64), and pancreatic interventions (aOR 7.55; 95% CI 4.23-13.96). During long-term follow-up, DPD increased the risk of pancreatic intervention (aOR 9.71; 95% CI 5.37-18.30), recurrent pancreatitis (aOR 2.08; 95% CI 1.32-3.29), chronic pancreatitis (aOR 2.73; 95% CI 1.47-5.15), and endocrine pancreatic insufficiency (aOR 1.63; 95% CI 1.05-2.53). Central or subtotal pancreatic necrosis on computed tomography (OR 9.49; 95% CI 6.31-14.29) and a high level of serum C-reactive protein in the first 48 hours after admission (per 10-point increase, OR 1.02; 95% CI 1.00-1.03) were identified as independent predictors for developing DPD.At least 1 of every 4 patients with necrotizing pancreatitis experience DPD, which is associated with detrimental, short-term and long-term interventions, and complications. Central and subtotal pancreatic necrosis and high levels of serum C-reactive protein in the first 48 hours are independent predictors for DPD.